1. Home
  2. LEVI vs CYTK Comparison

LEVI vs CYTK Comparison

Compare LEVI & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Levi Strauss & Co

LEVI

Levi Strauss & Co

HOLD

Current Price

$20.38

Market Cap

9.1B

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.63

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEVI
CYTK
Founded
1853
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.0B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
LEVI
CYTK
Price
$20.38
$63.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
17
Target Price
$26.31
$85.24
AVG Volume (30 Days)
2.4M
1.7M
Earning Date
01-28-2026
02-26-2026
Dividend Yield
2.88%
N/A
EPS Growth
178.65
N/A
EPS
1.45
N/A
Revenue
$6,282,000,000.00
$87,211,000.00
Revenue This Year
$6.56
$341.94
Revenue Next Year
$5.12
$75.44
P/E Ratio
$13.39
N/A
Revenue Growth
4.14
2609.26
52 Week Low
$12.17
$29.31
52 Week High
$24.82
$70.98

Technical Indicators

Market Signals
Indicator
LEVI
CYTK
Relative Strength Index (RSI) 43.19 49.34
Support Level $19.19 $62.05
Resistance Level $20.75 $67.10
Average True Range (ATR) 0.71 2.56
MACD -0.17 0.02
Stochastic Oscillator 37.46 42.20

Price Performance

Historical Comparison
LEVI
CYTK

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: